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Introduction 
Intraperitoneal (IP) chemotherapy is fundamentally different from conventional intravenous chemotherapy, since 
tumor nodules are brought into direct contact with the cytotoxic drug solution instead of convective drug transport 
through the circulation. The aim of IP chemotherapy is to increase the intratumorous drug concentration, while 
limiting the systemic drug dose and undesired side effects. IP therapy is mainly used to treat patients with peritoneal 
carcinomatosis, i.e. a wide-spread growth of tumor nodules on the peritoneal membrane which is often a metastatic 
disease with a poor survival prognosis. Although IP chemotherapy is a promising technique
[1]
, the current drawback 
is the limited drug penetration depth in the tumor tissue. Therefore, we studied the impact of a number of parameters 
on the transport of a cytotoxic drug in a single tumor nodule using a porous medium modeling approach. 
 
Methods 
A 3D computational fluid dynamics (CFD) model of a single 
tumor nodule and its simplified vascular network (Figure 1) 
was created. To model the tissue, an isotropic porous medium 
model was used and the vasculature was modeled as a fluid 
domain. A parameter study was performed in which the drug 
diffusivity (9*10
-9
, 9*10
-10
 and 9*10
-11
 m
2
/s), tissue 
permeability (10
-14
 and 10
-13 
m
2
) and mass fraction of chemo 
at the tumor edge (10% and 20%) were varied. 
 
Results 
The results of the parameter study showed different effects on 
local and systemic concentrations. Increasing the mass fraction 
from for 10% to 20%, for example, lead  to a doubling (3·10
-4
 to 
6·10
-4
 kmol/m
3
 after 1500 s  of therapy) (Figure 2a) of the systemic 
concentration, but only a very limited increase in penetration depth 
of the drug in the tissue (Figure 2b). Increasing the drug diffusivity 
from 9*10
-9
 to 9*10
-10
 m
2
/s on the other hand resulted in an increase 
in both local penetration and systemic concentrations (an added 5 
mm of penetration depth for an increase from 3,2·10
-4
 to 9,3·10
-3
 
kmol/m
3
 after 1500 s of therapy). Increasing the tissue permeability 
resulted in higher systemic concentrations of chemo and a minor 
increase in penetration depth, but the response to permeability 
changes was found to be strongly non-linear.   
 
Conclusion 
Initial results indicate that the model is able to simulate the impact 
of different drug and tissue properties on both the local and systemic 
drug concentration. Future work will focus on extending the model 
to more realistic configurations (e.g. by taking into account 
interstitial fluid pressures) and validation of the parameters.  
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Figure 1: Visualization of the model geometry showing the tumor 
tissue, its vasculature and the applied boundary conditions 
Figure 2: (b) Systemic concentration of chemo in function 
of time 
Figure 2: (a) Mass fraction of chemo in function of 
penetration depth 
